{
  "ticker": "IMU",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969768",
  "id": "02969768",
  "pages": 12,
  "price_sensitive": true,
  "date": "20250716",
  "time": "1036",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250716/pdf/06lv9l77343kcy.pdf",
  "summary": "### **Capital Raising Announcement Summary**  \n\n#### **Structure & Details**  \n- **Type**:  \n  - **Placement** ($22.5M) + **Share Purchase Plan (SPP)** ($15M)  \n- **Price**: **$0.33/share** (19.6% discount to 5-day VWAP)  \n- **Attaching Options**:  \n  - 3 free options per 4 new shares (exercise price **$0.43**, expiry **30 Mar 2026**).  \n  - **Piggyback Option**: 1 free option per Attaching Option exercised (exercise price **$0.86**, expiry **30 Jun 2028**).  \n- **Total Potential Proceeds**: Up to **$36.6M** if all options exercised.  \n\n#### **Use of Funds**  \n- Fund **azer-cel clinical trial** (pivotal trial expected CY26).  \n- Extend cash runway into **mid-CY27** (post-raise pro forma cash: **$64M**).  \n\n#### **Key Dates**  \n- **SPP Record Date**: 15 Jul 2025  \n- **Placement Settlement**: 24 Jul 2025  \n- **SPP Close**: 18 Aug 2025  \n- **Option Allotment**: 25 Aug 2025  \n\n#### **Other Material Points**  \n- **Discount**: 22.4% to last close ($0.425) / 19.6% to 5-day VWAP ($0.4107).  \n- **Shortfall Options**: Up to 4.4M additional options may be issued for SPP shortfall.  \n\n*Focus: Liquidity boost, extended runway, and optionality via attached derivatives.*",
  "usage": {
    "prompt_tokens": 6005,
    "completion_tokens": 369,
    "total_tokens": 6374,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-16T01:02:15.210643"
}